When food reaches the small intestine, it triggers the release of GLP-1, leading to a feeling of fullness, and stimulates the release of insulin, which lowers blood sugar
Now the challenge was to find a small molecule that also fits that pocket
Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356
Preclinical studies demonstrate that GLP-1 receptor agonists reduce food-seeking behavior and suppress dopamine signaling specifically in reward circuits
In clinical trials, patients taking the highest dose (15 mg weekly) lost an average of 48 pounds over 72 weekssignificantly more than with semaglutide
Among DS individuals, increased risk of AD, as well as low-intensity behavioral and emotional disorders have been observed when compared to euploid subjects (Silverman 2007)